Impact of Serum Levels of AFP on response to treatment in genotype 4 chronic HCV patients

Aisha Mahmoud Abdel-Aziz;

Abstract


Therapy of chronic hepatitis C has greatly improved in recent years, especially with the addition of ribavirin to interferon and with the use of PEG-IFN with ribavirin. Although AFP is used as a diagnostic marker of HCC, mild elevation can be seen in viru


Other data

Title Impact of Serum Levels of AFP on response to treatment in genotype 4 chronic HCV patients
Authors Aisha Mahmoud Abdel-Aziz
Keywords Impact of Serum Levels of AFP on response to treatment in genotype 4 chronic HCV patients
Issue Date 2007
Description 
Therapy of chronic hepatitis C has greatly improved in recent years, especially with the addition of ribavirin to interferon and with the use of PEG-IFN with ribavirin. Although AFP is used as a diagnostic marker of HCC, mild elevation can be seen in viru

Attached Files

File SizeFormat
4617afp.pdf571.91 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 1 in Shams Scholar
downloads 1 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.